Trane Technologies plc (TT): price, analyst ratings, earnings and fundamentals

Updated 30 October 2026, 21:45 ET

Trane Technologies plc (TT) closed at $410.00 on 30 October 2026, down 4.9%. The stock is down 10.7% over one month and down 4.1% over one year. It trades 19.0% below its 52-week high of $505.87. Analysts recorded 8 actions in the last 90 days; the median price target of $555 is 35.4% above the last close. The company last reported on 29 October 2026 for Q3 2026: EPS of $4.86 against an estimate of $4.74, a beat of 2.5%, on revenue of $6.8 billion.

Price and performance

Last close$410.00
Day change-4.89%
1 week-7.84%
1 month-10.66%
3 months-11.10%
6 months-15.72%
Year to date+5.34%
1 year-4.09%
52-week high$505.87
52-week low$348.06
Volume2,211,443
Average volume, 3 months1,175,168
Market cap$94.9B

Performance figures use dividend and split adjusted closes over trading sessions, so a one-year move compares the last close with the close 252 sessions earlier. The 52-week range uses the adjusted daily highs and lows of the same window. Read the guide: Momentum, trend and technical indicators.

The live chart with technical indicators is in the app: open TT in FundSpec.

Analyst ratings

Over the last 90 days FundSpec recorded 8 analyst actions on TT from 7 firms: 5 maintained or reiterated a view, 1 upgrade and 2 initiations. Price targets were 4 raised and 2 lowered. The most recent targets from 8 firms range from $485 to $575, with a median of $555, 35.4% above the last close.

Actions, 90 days8
Firms7
Median target$555
Target range$485 to $575
Median vs close+35.37%
DateFirmActionPrice target
30 Oct 2026RBC CapitalMaintains Sector Perform$502.00 to $486.00
30 Oct 2026Evercore ISI GroupMaintains Outperform$565.00 to $560.00
15 Oct 2026MizuhoMaintains Neutral$475.00 to $485.00
14 Oct 2026Goldman SachsUpgrades to Buy from Neutral$548.00 to $565.00
14 Oct 2026RBC CapitalMaintains Sector Perform$496.00 to $502.00
9 Oct 2026JP MorganReinstates Overweight$550.00
25 Sep 2026Wells FargoInitiates Coverage On Overweight$536.00
14 Aug 2026BernsteinMaintains Outperform$555.00 to $575.00
31 Jul 2026RBC CapitalMaintains Sector Perform$501.00 to $496.00
31 Jul 2026CitigroupMaintains Buy$570.00 to $566.00

A price target is one firm's twelve-month view, and the median across firms is a steadier reading than any single call. Upgrades and downgrades matter more when they change a rating, not only a target. Read the guide: What analyst ratings and price targets actually tell you.

Every action with the firm's history is in Analyst Ratings.

Earnings

The next report is scheduled for 28 January 2027 before the open for Q4 2026, with EPS expected at $3.50 on revenue of $6.0 billion. Trane Technologies plc beat the EPS estimate in 8 of its last 8 reported quarters.

PeriodReportedEPS estimateEPS actualSurpriseRevenue
Q3 202629 Oct 2026$4.74$4.86+2.53%$6.8B
Q2 202630 Jul 2026$4.25$4.31+1.41%$6.4B
Q1 202630 Apr 2026$2.53$2.63+3.95%$5.0B
Q4 202529 Jan 2026$2.82$2.86+1.42%$5.1B
Q3 202530 Oct 2025$3.79$3.88+2.37%$5.7B
Q2 202530 Jul 2025$3.78$3.88+2.65%$5.7B
Q1 202530 Apr 2025$2.20$2.45+11.36%$4.7B
Q4 202430 Jan 2025$2.54$2.61+2.76%$4.9B

An earnings surprise is the reported EPS against the consensus estimate on the day. The price reaction depends as much on guidance and on what was already priced in as on the surprise itself. Read the guide: Earnings season: estimates, surprises and price reaction.

Estimates, confirmed dates and alerts for every company are in Earnings.

Fundamentals

For the period ended 30 September 2026, Trane Technologies plc reported revenue of $6.8 billion and net income of $1.0 billion. On a trailing twelve month basis the company shows revenue growth of 10.34%, a gross margin of N.A., an operating margin of 17.92% and a return on equity of 36.13%.

Income statement

LineAmount
Revenue$6,759,700,000
Cost of Revenue$4,374,900,000
Gross Profit$2,384,800,000
Selling, General & Administrative Expenses$1,041,700,000
Depreciation & Amortization$105,000,000
Total Operating Expenses$5,416,600,000
Operating Profit$1,343,100,000
Interest Expense$52,400,000
Pre-tax Income$1,285,300,000
Income Tax Expense$219,900,000
Net Income$1,048,700,000

Cash flow

LineAmount
Cash from Operating Activities$1,313,300,000
Stock-based Compensation$26,700,000
Cash from Investing Activities-$188,000,000
Capital Expenditures$108,100,000
Cash from Financing Activities-$1,212,800,000
Dividends Paid$230,500,000
Share Repurchases$582,100,000
Free Cash Flow$1,205,200,000

Assets

LineAmount
Cash & Cash Equivalents$1,763,300,000
Inventory$2,602,500,000
Other Current Assets$792,000,000
Total Current Assets$8,711,400,000
Plant, Property & Equipment, Net$2,456,200,000
Goodwill Intangible Assets, Net$10,559,000,000
Deferred Tax Asset$808,600,000
Other Long-term Assets$2,163,600,000
Total Assets$23,890,200,000

Liabilities and equity

LineAmount
Accounts Payable & Accrued Expenses$3,103,300,000
Deferred Liability Charges$1,980,500,000
Total Current Liabilities$7,752,100,000
Long-term Debt$3,924,500,000
Operating Lease Liabilities, Long-term$824,700,000
Long-term Deferred Liability Charges$0
Minority Interest$22,800,000
Other Liabilities$1,746,200,000
Total Liabilities$14,757,400,000
Common Stock$242,600,000
Retained Earnings$11,026,700,000
Treasury Stock-$1,649,100,000
Other Accumulated Comprehensive Income-$510,200,000
Total Stockholders Equity$9,110,000,000
Total Liability & Stockholders Equity$23,890,200,000

Figures as filed with the SEC for the period ended 30 September 2026, in US dollars.

FundSpec fundamental metrics

Each metric is computed from the company's filings and ranked against every company FundSpec covers; the percentile is the share of covered companies with a lower value.

Liquidity

MetricValuePercentileWhat it measures
Cash Ratio0.2347thCalculated as the ratio of Cash and cash equivalents / Current liabilities. This metric calculates the company's ability to repay its short-term debt
Current Ratio1.1248thCalculated as the ratio of Current Assets / Current Liabilities. The higher the current ratio, the more capable the company is of paying its obligations

Leverage

MetricValuePercentileWhat it measures
Debt/Assets0.1663rdCalculated as the ratio of Short-Term Debt + Long-Term Debt / Total Assets. The higher the ratio, the higher the degree of leverage, and consequently, financial risk
Debt/Equity0.4359thCalculated as the ratio of Total Liabilities / Shareholders' Equity. The ratio indicates how much debt a company is using to finance its assets relative to the amount of value represented in shareholders’ equity
Degree of Combined Leverage0.5350thThis ratio summarizes the combined effect that the degree of operating leverage (DOL) and the degree of financial leverage have on earnings per share (EPS), given a particular change in sales
Degree of Financial Leverage1.0562ndCalculated as the ratio of Percentage change in EPS / Percentage change in EBIT. A higher degree of financial leverage means that the company has more volatile EPS.
Degree of Operational Leverage0.5151stCalculated as the ratio of Percentage change in EBIT / Percentage change in revenue. It is a measure of how earnings for the company is impacted by its sales activity.
Long Term Debt/Long Term Capital0.3039thCalculated as Long-Term Debt / (Long-Term Debt + Shareholders' Equity). The ratio is an indicator of the company's leverage

Earnings Growth (EBIT)

MetricValuePercentileWhat it measures
EBIT Pct Growth5.2%28thThe EBIT growth rate over the trailing twelve months (TTM)
EBIT Pct Growth 3 year CAGR14.3%64thThe EBIT compound annual growth rate (CAGR) over the past 3 years

Earnings Growth (EBITDA)

MetricValuePercentileWhat it measures
EBITDA Pct Growth5.3%26thThe EBITDA growth rate over the trailing twelve months (TTM)
EBITDA Pct Growth 3 year CAGR46.0%25thThe EBITDA compound annual growth rate (CAGR) over the past 3 years

Profitability

MetricValuePercentileWhat it measures
Free Cashflow Margin Pct16.4%77thCalculated as the ratio of Free Cashflow from Operating Activities / Net Sales. It measures how much per dollar of revenue the company is able to convert into free cash flow.
Operating Margin Pct17.9%78thCalculated as the ratio of (Revenue - (Cost of Goods Sold + Labour + Sales, General & Administrative)) / Revenue. Operating margins are important because they measure efficiency. The higher the operating margin, the more profitable a company's core business is.
Operating Profit Pct Growth5.2%49thThe Operating Profit growth rate over the trailing twelve months (TTM)
Operating Profit Pct Growth 3 year CAGR (FY)14.3%66thThe Operating Profit compound annual growth rate (CAGR) over the past 3 years
Operating Profit Pct Growth 5 year CAGR (FY)16.1%76thThe Operating Profit compound annual growth rate (CAGR) over the past 5 years
PreTax Margin Pct16.6%74thCalculated as the ratio of (Gross profit - (Operating Expense + Interest Expense)) / Revenue. The pretax profit margin enables profitability to be compared across companies with significant differences in size, scale, capital structure and tax rates.
Return on Assets Pct13.9%94thCalculated as the ratio of Net Income / Total Assets. It is an indicator of how efficient the company is at using its assets to generate earnings.
Return on Equity Pct36.1%93rdCalculated as the ratio of Net Income / Shareholders' equity. It is a measure of how much profit a company generates with the money shareholders have invested.
Return on Invested Capital Pct27.1%93rdCalculated as the ratio of (Net Income - Dividends) / (Debt + Equity). It is a measure of how efficient the company is at allocating the capital under its control to profitable investments.

Cashflow

MetricValuePercentileWhat it measures
FCF Pct Growth50.7%73rdThe Free Cash Flow growth rate over the trailing twelve months (TTM)
FCF Pct Growth 3 year CAGR99.9%75thThe Free Cash Flow compound annual growth rate (CAGR) over the past 3 years
FCF Pct Growth 5 year CAGR137.1%73rdThe Free Cash Flow compound annual growth rate (CAGR) over the past 5 years
FCF Return on Assets Pct16.9%94thCalculated as the ratio of Cashflow from Operations / Total Assets. A high cash return on assets means a company is generating more cash flow from every asset dollar
Operating Cashflow Pct Growth42.6%72ndThe Operating Cashflow growth rate over the trailing twelve months (TTM)
Operating Cashflow Pct Growth 3 year CAGR (FY)23.6%77thThe Operating Cashflow compound annual growth rate (CAGR) over the past 3 years
Operating Cashflow Pct Growth 5 year CAGR (FY)18.5%81stThe Operating Cashflow compound annual growth rate (CAGR) over the past 5 years

Earnings Growth (Net Income)

MetricValuePercentileWhat it measures
Net Income Pct Growth7.5%48thThe Net Income growth rate over the trailing twelve months (TTM)
Net Income Pct Growth 3 year CAGR17.2%72ndThe Net Income compound annual growth rate (CAGR) over the past 3 years
Net Income Pct Growth 5 year CAGR18.5%79thThe Net Income compound annual growth rate (CAGR) over the past 5 years

Top Line Growth

MetricValuePercentileWhat it measures
Revenue Pct Growth10.3%62ndThe Revenue (Sales) growth rate over the trailing twelve months (TTM)
Revenue Pct Growth 3 year CAGR10.3%66thThe Revenue (Sales) compound annual growth rate (CAGR) over the past 3 years
Revenue Pct Growth 5 year CAGR11.1%64thThe Revenue (Sales) compound annual growth rate (CAGR) over the past 5 years

Taxes

MetricValuePercentileWhat it measures
Effective Tax Rate Pct17.8%61stThe effective tax rate of the company over the trailing twelve months (TTM).

Margins and returns say how much of each dollar of sales becomes profit and how hard the balance sheet is working; leverage and liquidity say how much room the company has when conditions turn. Read the guide: A practical guide to discounted cash flow valuation.

Fair value, peer multiples and the full statement history are in the app: open TT in FundSpec.

Insider activity

In the last 90 days insiders filed 7 transactions. Acquisitions include awards and option exercises as well as open market purchases. The largest by value was a disposal of 48,091 shares by David S Regnery, Director, Chair and CEO on 6 October 2026, worth about $23.1 million at the transaction price.

DateInsiderTitleTypeSharesPriceValue
6 Oct 2026David S RegneryDirector, Chair and CEOS48,091$480.00$23.1M
6 Oct 2026David S RegneryDirector, Chair and CEOM48,091$78.97$3.8M
6 Oct 2026David S RegneryDirector, Chair and CEOM48,091
5 Aug 2026David S RegneryDirector, Chair and CEOS43,778$475.00$20.8M
5 Aug 2026David S RegneryDirector, Chair and CEOM43,778$70.22$3.1M
5 Aug 2026David S RegneryDirector, Chair and CEOM43,778
4 Aug 2026Melissa N. SchaefferDirectorS145$472.27$68K
1 Jul 2026Donald E. SimmonsEVP & Chief Operating OfficerAcquisition826
1 Jul 2026Donald E. SimmonsEVP & Chief Operating OfficerAcquisition3,085
5 Jun 2026Myles P LeeDirectorF224$456.84$102K
5 Jun 2026Jesus Assis Ana Paula DeDirectorF224$456.84$102K
5 Jun 2026Mark R GeorgeDirectorF112$456.84$51K
5 Jun 2026Boise April MillerDirectorF112$456.84$51K
5 Jun 2026Ann C BerzinDirectorF112$456.84$51K
5 Jun 2026John P SurmaDirectorF112$456.84$51K

Insider filings record what officers and directors did with their own shares. Disposals are often planned sales or tax related, so a pattern across several insiders says more than one filing.

SEC filings

The latest filing is a 10-Q from 29 October 2026.

FiledFormDocument
29 Oct 202610-QView on sec.gov
30 Jul 202610-QView on sec.gov
30 Apr 202610-QView on sec.gov
5 Feb 202610-KView on sec.gov
30 Oct 202510-QView on sec.gov
30 Jul 202510-QView on sec.gov
30 Apr 202510-QView on sec.gov
6 Feb 202510-KView on sec.gov
30 Oct 202410-QView on sec.gov
31 Jul 202410-QView on sec.gov

Company profile

Exchange
NYSE
Sector
Medical Devices and Instruments
Industry
Measuring And Control Equipment
Headquarters
CO. DUBLIN, North Carolina
Chief executive
Dave S. Regnery
Employees
39,000
Website
tranetechnologies.com
SEC CIK
0001466258

Trane Technologies plc engages in the designing, manufacturing, selling, and servicing of solutions for heating, ventilation, air conditioning, and transport refrigeration. The company also provides building management, control, ductless, geothermal, package heating and cooling, temporary heating, cooling, and unitary systems. It markets its products under the Trane and Thermo King brands through sales offices, distributors, and dealers.

Sector and peers

Trane Technologies plc is part of the Medical Devices and Instruments sector, which FundSpec tracks across 217 companies.

Companies in the same industry by market capitalization:

KLAC KLA Corp.COHR Coherent Corp.

Put two of them side by side in Compare.

In FundSpec: the fair value estimate, the momentum reading, relative valuation against sector and industry peers, unusual options activity and AI model signals for TT are available to subscribers, with the same screen in the iOS and Android apps.

Open TT in FundSpec